Viveve, Inc. (OTCQ: VIVMF), operating subsidiary of Viveve Medical, Inc., is a women’s health company committed to advancing new solutions to improve women’s overall well-being and quality of life. The company’s lead product, the globally patented Viveve® System, is a non-surgical, non-ablative medical device that treats the condition of vaginal laxity, which is the result of the over-stretching of tissue during childbirth that can result in a decrease in physical sensation and sexual satisfaction. The Viveve System has received regulatory approval in Europe, Canada and Hong Kong and is available through physician import license in Japan. For more information, visit the company’s website at www.viveve.com.